Literature DB >> 31468453

Protection of Taurine Against Neurotoxicity Induced by Arsenic in Primary Cortical Neurons.

Fengyuan Piao1, Xueying Zhou1, Dunjia Wang1, Jing Shao1, Yachen Li1, Xiaohui Liu1, Cong Zhang2, Enjun Zuo3, Xiaoxia Shi1, Shuangyue Li1.   

Abstract

Our group previously reported that taurine has a protective capacity on the hippocampus and cerebellum of arsenic (As)-exposed mouse. In the present study, we explore whether taurine demonstrates protection against As toxicity in primary cortical neurons. Primary cortical neurons were exposed to various concentrations of arsenite and cell viability was assessed to confirm the toxicity of As on cortical neurons. The protection of taurine was examined after primary cortical neurons were treating with arsenite and taurine for 24 h. The cell viability was examined by MTT and caspase-3 activity assay. The expression of Bax and Bcl-2 was determined by western blot. The results showed that As exposure reduced cell viability and enhanced the activity of caspase-3, which were markedly inhibited by taurine treatment. The expression of Bax and Bcl-2 were disturbed by As exposure, which were reversed by taurine. These results indicated that taurine expose protective effect on As-exposed primary cortical neurons and its mechanism maybe involved the regulation of Bax/Bcl-2.

Entities:  

Keywords:  Apoptosis; Arsenic; Neuroprotection; Taurine

Mesh:

Substances:

Year:  2019        PMID: 31468453     DOI: 10.1007/978-981-13-8023-5_73

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Minocycline as a Neuroprotective Agent in Arsenic-Induced Neurotoxicity in PC12 Cells.

Authors:  Mersedeh Shayan; Soghra Mehri; Bibi Marjan Razavi; Hossein Hosseinzadeh
Journal:  Biol Trace Elem Res       Date:  2022-08-08       Impact factor: 4.081

2.  Influences of Taurine Pharmacodynamics and Sex on Active Avoidance Learning and Memory.

Authors:  Wei Zhu; George B Cruz; Zaid Ayaz; Jewel N Joseph; Akil Boby; Patrick Cadet; Lorenz S Neuwirth
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.